Public health & disease

From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.

Young Asian Dermatologist is Using a Dermatoscope to Identify Worrying Cancerogenic Tissues on the Skin of a Senior Female, for article on melanoma metastasis research

Israeli researchers reach ‘breakthrough’ in fight against skin cancer

By / / Good News For Humankind

Melanoma may quietly build its own escape routes before it ever becomes dangerous, according to researchers at Tel Aviv University and Sheba Medical Center. They discovered that while the cancer is still confined to the skin’s outer layer, it releases tiny pigment-carrying vesicles called melanosomes that slip into the deeper dermis and coax lymph vessels to grow — essentially paving roads the tumor will later travel to spread. Because melanoma isn’t life-threatening until it leaves the skin, the team believes a vaccine could train the immune system to intercept those melanosomes first. With about 325,000 people diagnosed worldwide each year, this early-stage target could open a hopeful new chapter in shifting cancer treatment from reactive to preventive.

Silhouette of person holding cannabis leaf, for article on Minnesota cannabis legalization

Minnesota becomes 23rd U.S. state to legalize recreational marijuana

By / / Good News For Humankind

Minnesota’s new cannabis law will automatically clear tens of thousands of low-level marijuana convictions, pairing legalization with one of the most ambitious record-clearing efforts in the country. Adults 21 and older can now possess cannabis under the law Gov. Tim Walz signed in May 2023, making Minnesota the 23rd state to legalize recreational use. What sets it apart is the justice piece: people don’t have to navigate courts to clear their records — the state does it for them, opening doors to jobs, housing, and education long blocked by old convictions. As legalization spreads, Minnesota offers a model that finally asks who bore the costs of prohibition, and who deserves a fresh start.

Viruses under microscope, for article on RSV vaccine approval

U.S. FDA approves first-ever vaccine for RSV

By / / Good News For Humankind

Pfizer’s RSV vaccine ABRYSVO just became the first licensed option for at-risk adults as young as 18, closing a long-standing protection gap for younger people living with chronic conditions. About one in ten U.S. adults aged 18 to 49 has a condition like diabetes, asthma, or heart failure that raises their risk of severe RSV illness — and until now, they had nothing. The vaccine targets RSV’s prefusion F protein, a breakthrough that finally unlocked effective design after decades of frustrating research. With approvals now spanning pregnant individuals, older adults, and at-risk younger adults, ABRYSVO marks a quiet but powerful turning point in a field that struggled for half a century — a reminder that patient science eventually delivers real protection to real people.

Researcher looking at petri dish, for article on Parkinson's disease cause

Helsinki University makes Parkinson’s disease breakthrough

By / / Good News For Humankind

Parkinson’s disease may finally have a name attached to its cause: researchers at the University of Helsinki have identified specific strains of Desulfovibrio bacteria in the gut as the likely trigger behind most cases. Professor Per Saris estimates that about 90 percent of cases trace back to environmental exposure to these bacteria, with genetics accounting for only the remaining sliver. Because the culprit lives in the gut, it can in principle be screened for and cleared, opening a real path toward slowing the disease or preventing it before symptoms ever begin. For the eight million people worldwide living with Parkinson’s, and for a global health movement increasingly focused on the microbiome, knowing where to look changes everything.